HRTX 8-K 2026-11-09

HERON THERAPEUTICS, INC. /DE/ (HRTX) 8-K dated 2026-11-09 — accession 0001193125-26-452672.

HERON THERAPEUTICS, INC. /DE/ (HRTX) is a biotechnology company listed on US.

HERON THERAPEUTICS, INC. /DE/ filed a 8-K on 2026-11-09. Accession 0001193125-26-452672.

This 8-K covers: Material agreement (Item 1.01), Change to holders' rights (Item 3.03), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported HRTX revenue for 2025-12-31 was $154.9M. Net income was -$20.2M. Revenue was up 7.4% from 2024-12-31 to 2025-12-31. HRTX currently screens at market cap $332.6M.

Not investment advice. The HRTX SEC hub lists recent forms. The stock page is the research view.